Quarterly report pursuant to Section 13 or 15(d)

5. STOCK OPTION PLAN AND STOCK-BASED COMPENSATION

v3.2.0.727
5. STOCK OPTION PLAN AND STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2015
Notes to Financial Statements  
NOTE 5 - STOCK OPTION PLAN AND STOCK-BASED COMPENSATION

During the year ended December 31, 2010, the Company adopted a stock option plan entitled “The 2010 Stock Plan” (“2010 Plan”) under which the Company may grant options to purchase up to 5,000,000 shares of common stock.  On September 7, 2013, the 2010 plan was amended to increase the number of shares of common stock issuable under the 2010 Plan to 7,500,000.  As of June 30, 2015 and December 31, 2014, there were 5,646,600 and 6,171,600 options available for grant under the 2010 Plan, respectively.

 

During the year ended December 31, 2011, the Company adopted a non-qualified stock option plan entitled “2011 Non-Qualified Stock Plan” (“2011 Plan”) under which the Company may grant options to purchase 2,100,000 shares of common stock. During the period ended March 31, 2013, the 2011 Plan was amended to increase the number of shares of common stock issuable under the 2011 Plan to 17,500,000.  As of June 30, 2015 and December 31, 2014, there were 11,138,880 and 12,247,880 options available for grant under the 2011 Plan, respectively.

 

Under the terms of the stock plans, the Board of Directors shall specify the exercise price and vesting period of each stock option on the grant date. Vesting of the options is typically one to four years and the options typically expire in five to ten years.

 

In March 2015, the Board of Directors approved a grant of non-qualified stock options to the independent directors of the Company to purchase an aggregate of 384,000 shares of the Company’s common stock at an exercise price of $0.18. The options were allocated among the directors based on service in, and chairmanship of the Company’s committees and service as lead independent director. The options vest as of December 31, 2015, provided that the directors remain directors on that date and have attended at least 75% of the scheduled meetings of the Board and the committees on which such directors serve during the 2015 calendar year. In addition, during the period ended March 31, 2015, the Company granted incentive stock options to members of management and non-management of the Company to purchase an aggregate of 700,000 shares of the Company’s common stock at exercises prices ranging from $0.18 to $0.20 per share, all of which vested immediately. The Company also granted non-qualified stock options to consultants of the Company to purchase an aggregate of 625,000 shares of the Company’s common stock at an exercise price of $0.18, all of which vested immediately.

 

During the three months ended June 30, 2015, the Company granted a non-qualified stock option, to a consultant to purchase an aggregate of 100,000 shares of the Company’s common stock at an exercise price of $0.20, which vested immediately.

 

The fair value of stock options granted or revalued for the three and six months ended June 30, 2015 and 2014 was calculated with the following assumptions:

 

   

 

 2015

   

 

 2014

 
Risk-free interest rate     1.3% - 1.9 %     0.5% - 2.3 %
Expected dividend yield     0 %     0 %
Volatility factor     79 – 91 %     86 – 98 %
Expected life of option   4.60 to 10 years     2.50 to 7 years  

 

The weighted-average fair value of stock options granted during the six month period ended June 30, 2015 and 2014, under the Black-Scholes option pricing model, was $0.14 and $0.83 per share, respectively.

 

The Company recognized $36,071 and $106,215 of stock-based compensation costs in the accompanying statement of operations for the three months ended June 30, 2015 and 2014, respectively.  The Company recognized $241,246 and $609,987 of stock-based compensation costs in the accompanying statement of operations for the six months ended June 30, 2015 and 2014, respectively.  As of June 30, 2015, there was approximately $126,000 of unrecognized compensation expense related to non-vested stock option awards that is expected to be recognized over a weighted average period of 1.7 years. 

 

The following table summarizes the Company’s stock option activity during the six months ended June 30, 2015:

 

    Shares     Exercise Price per Share    

Weighted Average

Exercise Price per Share

 
Outstanding as of December 31, 2014     6,483,400     $ 0.10-1.85     $ 0.47  
      Granted     1,809,000       0.18-0.20       0.18  
      Exercised     -       -       -  
      Options forfeited/cancelled     (175,000 )     0.18-0.43       0.32  
Outstanding as of June 30, 2015     8,117,400     $ 0.10-1.85     $ 0.41  

 

There were no stock option exercises during the three or six months ended June 30, 2015.  During the three months ended March 31, 2014, the Company received a notice of cashless stock options exercise in which the holder elected to exercise 133,280 common stock options.  The stock options which were exercised had an exercise price of $0.57 per share.  Based upon the Company’s stock price on the date of exercise, as well as the cashless exercise formula, 79,016 shares were issued to the holder during the quarter ended March 31, 2014 with the remaining 54,264 options forfeited.  In addition, the Company also received $500 for stock options exercised. There were no stock option exercises during the three months ended June 30, 2014.

 

The following table summarizes information about stock options that are vested or expected to vest at June 30, 2015: 

 

Vested or Expected to Vest     Exercisable Options  
            Weighted     Weighted                 Weighted     Weighted        
            Average     Average                 Average     Average        
            Exercise     Remaining     Aggregate     Number     Exercise     Remaining     Aggregate  
Exercise     Number of     Price Per     Contractual     Intrinsic     of     Price     Contractual     Intrinsic  
Price     Options     Share     Life (Years)     Value     Options     Per Share     Life (Years)     Value  
$ 0.10       1,795,000     $ 0.10       1.38     $ 89,750       1,795,000     $ 0.10       1.38     $ 89,750  
  0.18       1,484,000       0.18       8.63       -       1,100,000       0.18       8.24       -  
  0.20       250,000       0.20       9.76       -       250,000       0.20       9.76       -  
  0.37       58,000       0.37       7.18       -       48,000       0.37       7.37       -  
  0.42       63,000       0.42       5.51       -       63,000       0.42       5.51       -  
  0.50       3,710,000       0.50       3.50       -       3,443,333       0.50       3.08       -  
  0.69       100,000       0.69       8.71       -       100,000       0.69       8.71       -  
  1.21       579,000       1.21       8.57       -       560,250       1.21       8.57       -  
  1.85       78,400       1.85       0.25       -       78,400       1.85       0.25       -  
$ 0.10-1.85       8,117,400     $ 0.41       4.60     $ 89,750       7,437,983     $ 0.41       4.16     $ 89,750  

 

The weighted-average remaining contractual life for stock options exercisable at June 30, 2015 is 4.16 years. The intrinsic value for fully vested, exercisable options was $89,750 and $1,518,880 at June 30, 2015 and December 31, 2014, respectively. There were no options exercised during the three or six months ended June 30, 2015.  The aggregate intrinsic value of options exercised during the three months ended March 31, 2014 was $71,083.   There were no option exercises in the three months ended June 30, 2014.  No actual tax benefit was realized from stock option exercises during these periods.

 

The following table sets forth the status of the Company’s non-vested stock options as of June 30, 2015:

 

   

Number of

Options

   

Weighted-Average

Grant-Date

Fair Value

 
Non-vested as of December 31, 2014     484,584     $ 0.39  
Granted     1,809,000       0.14  
Forfeited     (100,000 )     0.32  
Vested     (1,514,167 )     0.15  
Non-vested as of June 30, 2015     679,417     $ 0.25